Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness.

Lu CY, Soumerai SB, Ross-Degnan D, Zhang F, Adams AS.

Med Care. 2010 Jan;48(1):4-9. doi: 10.1097/MLR.0b013e3181bd4c10.

PMID:
19956079
[PubMed - indexed for MEDLINE]
2.

Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder.

Zhang Y, Adams AS, Ross-Degnan D, Zhang F, Soumerai SB.

Psychiatr Serv. 2009 Apr;60(4):520-7. doi: 10.1176/appi.ps.60.4.520.

PMID:
19339328
[PubMed - indexed for MEDLINE]
3.

Containing cost despite the cost.

Farley JF.

Med Care. 2010 Jan;48(1):1-3. doi: 10.1097/MLR.0b013e3181caad9a. No abstract available.

PMID:
19956078
[PubMed - indexed for MEDLINE]
4.

Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change.

Soumerai SB, Zhang F, Ross-Degnan D, Ball DE, LeCates RF, Law MR, Hughes TE, Chapman D, Adams AS.

Health Aff (Millwood). 2008 May-Jun;27(3):w185-95. doi: 10.1377/hlthaff.27.3.w185. Epub 2008 Apr 1.

PMID:
18381404
[PubMed - indexed for MEDLINE]
Free Article
6.

Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study.

Law MR, Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS.

Clin Ther. 2010 Apr;32(4):729-41; discussion 716. doi: 10.1016/j.clinthera.2010.04.007.

PMID:
20435243
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Association between prior authorization for medications and health service use by Medicaid patients with bipolar disorder.

Lu CY, Adams AS, Ross-Degnan D, Zhang F, Zhang Y, Salzman C, Soumerai SB.

Psychiatr Serv. 2011 Feb;62(2):186-93. doi: 10.1176/appi.ps.62.2.186.

PMID:
21285097
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.

Farley JF, Cline RR, Schommer JC, Hadsall RS, Nyman JA.

Clin Ther. 2008 Aug;30(8):1524-39; discussion 1506-7. doi: 10.1016/j.clinthera.2008.08.009.

PMID:
18803994
[PubMed - indexed for MEDLINE]
9.

Assessment of changes in utilization of health-care services after implementation of a prior authorization policy for atypical antipsychotic agents.

Walthour A, Seymour L, Tackett R, Perri M.

Ann Pharmacother. 2010 May;44(5):809-18. doi: 10.1345/aph.1M620. Epub 2010 Apr 13.

PMID:
20388858
[PubMed - indexed for MEDLINE]
10.

Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study.

Lu CY, Law MR, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS.

Clin Ther. 2011 Jan;33(1):135-44. doi: 10.1016/j.clinthera.2011.01.012.

PMID:
21397779
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements.

Law MR, Ross-Degnan D, Soumerai SB.

Psychiatr Serv. 2008 May;59(5):540-6. doi: 10.1176/appi.ps.59.5.540.

PMID:
18451014
[PubMed - indexed for MEDLINE]
12.

Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.

Jacobson Vann JC, Christofferson S, Humble CG, Wegner SE, Feaganes JR, Trygstad TK.

J Manag Care Pharm. 2010 May;16(4):250-63.

PMID:
20433216
[PubMed - indexed for MEDLINE]
Free Article
13.

Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder.

Guo JJ, Keck PE, Li H, Patel NC.

Psychiatr Serv. 2007 Aug;58(8):1073-8.

PMID:
17664518
[PubMed - indexed for MEDLINE]
14.

Healthcare costs of atypical antipsychotic use for patients with bipolar disorder in a Medicaid programme.

Qiu Y, Fu AZ, Liu GG, Christensen DB.

Appl Health Econ Health Policy. 2010;8(3):167-77. doi: 10.2165/11318830-000000000-00000.

PMID:
20408601
[PubMed - indexed for MEDLINE]
15.

Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P.

N Engl J Med. 1994 Sep 8;331(10):650-5.

PMID:
8052275
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population.

Hartung DM, Touchette DR, Ketchum KL, Haxby DG, Goldberg BW.

Clin Ther. 2004 Sep;26(9):1518-32.

PMID:
15531015
[PubMed - indexed for MEDLINE]
18.

Differences in the cost of antidepressants across state Medicaid programs.

Kelton CM, Rebelein RP, Heaton PC, Ferrand Y, Guo JJ.

J Ment Health Policy Econ. 2008 Mar;11(1):33-47.

PMID:
18424875
[PubMed - indexed for MEDLINE]
19.

Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.

Jing Y, Johnston SS, Fowler R, Bates JA, Forbes RA, Hebden T.

J Med Econ. 2011;14(6):777-86. doi: 10.3111/13696998.2011.625066. Epub 2011 Sep 29.

PMID:
21954966
[PubMed - indexed for MEDLINE]
20.

Medicaid's prior authorization program and access to atypical antipsychotic medications.

Polinski JM, Wang PS, Fischer MA.

Health Aff (Millwood). 2007 May-Jun;26(3):750-60.

PMID:
17485754
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk